8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T19623 | α-Muricholic acid | AChR | |
α-Muricholic acid is the most abundant primary bile acid in rodents. | |||
T37416 | Tauro-α-muricholic Acid (sodium salt) | ||
Tauro-α-muricholic acid (TαMCA) is an antagonist of the farnesoid X receptor (FXR; IC50 = 28 μM) and a taurine-conjugated form of the murine-specific primary bile acid α-muricholic acid . TαMCA is common in rodents but h... | |||
T63793 | Tauro-ω-muricholic acid sodium | ||
Tauro-ω-muricholic acid sodium (TωMCA sodium) is an analogue of tauro-α-muricholic acid, a bile acid of hepatic origin. Tauro-ω-muricholic acid sodium can be used as a serum marker for early onset neonatal sepsis (EOS) a... | |||
T40790 | ω-Muricholic Acid | ||
ω-Muricholic acid (ω-MCA) is a murine-specific secondary bile acid. | |||
T81030 | Tauro-β-muricholic acid | TβMCA | FXR |
Tauro-β-muricholic acid (TβMCA), a trihydroxylated bile acid, acts as a competitive and reversible FXR antagonist (IC 50 = 40 μM) and exhibits antiapoptotic effects by inhibiting bile acid-induced hepatocellular apoptosi... | |||
T13093 | Tauro-β-muricholic acid sodium | T-βMCA sodium | FXR |
Tauro-β-muricholic Acid sodium is a endogenous metabolite, is a competitive and reversible antagonist of farnesoid X receptor (FXR)(IC50 of 40 μM). | |||
T37997 | Murideoxycholic Acid | ||
Murideoxycholic acid (MDCA) is a secondary bile acid produced from α-muricholic acid and β-muricholic acid.[1] It is also a metabolite of lithocholic acid in liver S9 fractions from humans and other species.[2] MDCA prev... | |||
T35400 | β-Muricholic Acid | β-MCA,5β-Cholanic Acid-3α,6β,7β-triol,β-Muricholic Acid | |
β-Muricholic acid (β-MCA) is a murine-specific primary bile acid.[1],[2] Dietary administration of β-MCA reduces HMG-CoA reductase activity in liver microsomes from mice fed a high cholesterol and cholic acid diet.[3] Di... |